CARLSBAD, CA — Excaliard Pharmaceuticals, a late stage preclinical company developing targeted therapeutics for the treatment of dermatological disorders and fibrotic diseases, is pleased to announce the appointment of Lincoln Krochmal, MD, as President & Chief Executive Officer and Jeff Jensen as Head of Clinical Operations.
Proceeds to be Used for Advancement of Cancer Stem Cells and Other Development Programs
ROCKVILLE, MD — MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that it has raised $25 million in a Series D-2 financing. The round, led by Nextech Venture, included additional new investors Arcus Ventures, Innovis Investments and Eli Lilly and Company. Also participating in the financing were existing investors Alexandria Real Estate, Alta Partners, CIDC, InterWest Partners, Mitsubishi UFJ, OrbiMed Advisors, Red Abbey Venture Partners, RiverVest, Texas Pacific Group Ventures and Ventures West.
Application Will Create Adaptive Gating Capability With Other Applications to Follow
CONCORD, CA AND SEATTLE, WA – Calypso Medical Technologies, Inc. (Calypso Medical) and Siemens Healthcare today announced a product collaboration agreement that will begin to integrate Calypso Medical’s real-time tumor tracking data with Siemens’ linear accelerator products. The first application to be addressed under this agreement will include adaptive gating, the capability of automatically interrupting the radiation beam from a linear accelerator in response to patient motion, organ motion or tumor position.
Adaptive Workflow Efficiency Release Highlighted at the American Society of Therapeutic Radiology (ASTRO) 50 Annual Meeting
BOSTON, MA — Calypso® Medical Technologies, Inc. today announced the launch of the Adaptive Workflow Efficiency release, developed to provide connectivity between the Calypso® 4D Localization System™ and Varian Medical Systems’ 4D integrated treatment console (4DITC). The Adaptive Workflow Efficiency release is a product upgrade for current customers and will be showcased by Calypso Medical at the ASTRO 50th Annual Meeting at the Boston Convention and Exhibition Center on September 21 - September 25, 2008.
Company Prepares to Commercialize New Endometrial Indication as Adoption for its Breast Cancer Application Continues to Grow
SUNNYVALE, CA – Xoft, Inc., developer of Electronic Brachytherapy (eBx), a proprietary cancer treatment platform, announced today that the company has closed its Series E preferred stock financing, raising a total of $25 million in additional funding.
